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Abstract
Low vitamin D levels are associated with an increased incidence of colorectal cancer (CRC) and higher mortality from the
disease. In the US, African Americans (AAs) have the highest CRC incidence and mortality and the lowest levels of vitamin D.
Single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene have been previously associated with CRC,
but few studies have included AAs. We studied 795 AA CRC cases and 985 AA controls from Chicago and North Carolina as
well as 1324 Caucasian cases and 990 Caucasian controls from Chicago and Spain. We genotyped 54 tagSNPs in VDR
(46586959 to 46521297 Mb) and tested for association adjusting for West African ancestry, age, gender, and multiple
testing. Untyped markers were imputed using MACH1.0. We analyzed associations by gender and anatomic location in the
whole study group as well as by vitamin D intake in the North Carolina AA group. In the joint analysis, none of the SNPs
tested was significantly associated with CRC. For four previously tested restriction fragment length polymorphisms, only
one (referred to as ApaI), tagged by the SNP rs79628898, had a nominally significant p-value in AAs; none of these
polymorphisms were associated with CRC in Caucasians. In the North Carolina AAs, for whom we had vitamin D intake data,
we found a significant association between an intronic SNP rs11574041 and vitamin D intake, which is evidence for a VDR
gene-environment interaction in AAs. In summary, using a systematic tagSNP approach, we have not found evidence for
significant associations between VDR and CRC in AAs or Caucasians.
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Introduction
Vitamin D has numerous physiological effects, including effects
on regulation of calcium homeostasis, immunity, insulin secretion,
and blood pressure. Vitamin D3 (cholecalciferol) is formed from
the precursor steroid 7-dehydrocholesterol (7-DHC), which is
concentrated in the plasma membrane of the basal keratinocytes in
the skin [1]. Upon stimulation of sunlight (UVB, 280–320 nm), 7-
DHC is converted to vitamin D3. Vitamin D3 is converted in the
liver to 25(OH)D3 (calcidiol) and in the tissues to 1,25(OH)2D3
(calcitriol), which is the most active form of the vitamin. Serum
25(OH)D3 level, which is the most widely accepted indicator of
vitamin D status, is the sum of dietary/supplementary intake and
endogenous synthesis. That said, up to 95% of vitamin D is
attributable to synthesis in the skin with sunlight exposure, because
there are relatively few dietary sources that contain vitamin D [2].
Factors that negatively impact vitamin D status include lack of sun
exposure, lack of vitamin D intake, dark skin, aging, and obesity
among others.
Garland and Garland [3] first suggested the vitamin D
hypothesis so called because they found a correlation between
latitude and colorectal cancer (CRC) prevalence. Multiple studies
have since shown that vitamin D status can influence the risk of
developing CRC. Meta-analyses of case-control studies have
shown vitamin D intake and levels of serum 25(OH)D3 are
associated with CRC [4,5] and adenomatous colonic polyps [6]. In
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supplementation was found to inhibit colon carcinogenesis [7–
10]. 25(OH)D3 inhibits cell proliferation and induces apoptosis of
CRC cell lines, and it has similar effects in the colon in animal
models and in humans [11–13].
Cutaneous melanin absorbs the UVB wavelengths, and it
attenuates the synthesis of vitamin D. In Hollis’ 1991 study [14],
after treatment with UVB, Caucasian subjects generated the
highest levels of serum 25(OH)D3 whereas African Americans
(AAs) generated the lowest levels. As might be expected in
comparisons of persons at similar latitudes, AAs have the lowest
levels of serum 25(OH)D3 of any US population [15]. Consistent
with a negative correlation between vitamin D levels and CRC,
AAs have the highest CRC incidence and mortality of any US
population. Because low serum 25(OH)D3 is associated with CRC,
vitamin D status could play an important role in CRC risk in the
AA population. Vitamin D may also play an important role in
CRC mortality in AAs [16].
The 1,25(OH)2D3 metabolite binds to and activates the vitamin
D receptor (VDR), which regulates transcription of numerous
downstream genes. Genetic variants in the VDR gene have been
previously associated with CRC and colonic adenoma risk;
however, VDR association results have been inconsistent [17–
43]. Many studies have focused on polymorphisms of conve-
nience (restriction fragment length polymorphisms—RFLPs—
and microsatellites), including variants defined by polymorphisms
in TaqI (rs731236), BsmI (rs1544410), and ApaI (rs7975232)
restriction-enzyme sites and a polymorphic adenine mononucle-
otide run [21–26,28,30,32–34,37]. Some studies focused on
possible functional variants, for example, the FokI RFLP
(rs10735810) and a polymorphism (rs11568820) in the caudal-
related homeodomain protein Cdx-2 binding element in the
promoter of VDR [22,23,25,27,28,31,32,35–37,39–41]. Previous
work has also suggested that haplotypes that include these
variants are associated with CRC [38]. Only two published
studies have taken a systematic approach to testing single
nucleotide polymorphisms (SNPs) that tag most of the common
genetic variation in VDR. Using a tagSNP approach, Poynter [42]
and Egan [43] and their colleagues did not find significant
associations between VDR SNPs and CRC or colonic adenoma,
respectively, in individuals of European descent. Because the
vitamin D pathway could play an important role in CRC in AAs,
here we have tested whether VDR tagSNPs are associated with
CRC in both AAs and Caucasians.
Table 1. Clinical characteristics of African American and Caucasian study groups.
African-Americans Caucasians
Study group Cases Controls Cases Controls
Number of subjects Total 795 985 1317 978
UC 404 568 399 367
UNC 391 417
Spain 918 611
Mean age, years (SD) Total 64.5 (11.7)* 62.3 (13.2)* 68.1 (11.5)* 65 (12.3)*
UC 67.3 (12.7) 60.2 (15.8) 64.6 (13.1) 61.1 (12.7)
UNC 61.8 (10.0) 65.2 (9.6)
Spain 71.6 (9.9) 68.9 (11.8)
Gender (F/M) Total 423/372‘ 570/412‘ 513/803‘‘ 446/528‘‘
UC 230/172 375/190 170/229 181/183
UNC 193/200 195/222
Spain 343/574 265/345
% West African ancestry (SD) Total 84.1 (14.0) 85.5 (14.3)
UC 85.6 (14.8) 87.8 (13.7) 1.0 (1.5) 0.9 (1.3)
UNC 82.7 (12.9) 82.4 (14.6)
Anatomic site, n (%)
Colon Total 605 (76.4) 814 (68.3)
UC 337 (84.0) 248 (62.3)
UNC 268 (68.5)
Spain 566 (71.4)
Rectum Total 187 (23.6) 377 (31.7)
UC 64 (16.0) 150 (37.7)
UNC 123 (31.5)
Spain 227 (28.6)
UC, University of Chicago; UNC, University of North Carolina; Spain, Epicolon Spanish consortium; SD, standard deviation; F, female; M, male; colon, proximal to and
including sigmoid colon cancers; rectum, rectal and rectosigmoid cancers.
All p-values for heterogeneity between total cases and controls $0.05 unless otherwise indicated by footnote symbols.
*p-value for heterogeneity, ,0.001;
‘p-value, 0.04;
‘‘p-value, 0.001.
doi:10.1371/journal.pone.0026123.t001
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Ethics Statement
All three studies were approved by their respective institutional
review boards, and where appropriate, subjects provided written
informed consent.
Cases and Controls
Cases and controls were obtained from the University of
Chicago (UC), the University of North Carolina (UNC) and the
Spanish CRC consortium EPICOLON (SP). In total, we included
DNA from 795 AA CRC cases (404 UC, 391 UNC) and 985 AA
controls (568 UC, 417 UNC) as well as 1324 Caucasian cases (399
UC, 925 SP) and 990 Caucasian controls (367 UC, 623 SP). DNA
samples from UC cases and controls were prepared from archived
surgical specimens as described previously [44]. Additional UC
cases were also obtained prospectively from the oncology clinic
between 2006–2007 and UC cancer-free controls from the
gastroenterology clinic in 2009 (individuals found to have a
normal screening colonoscopy) or from the UC Translational
Research Initiative (2005–2008).
Samples from UNC were obtained through a large-scale
population-based case-control study of colon and rectal cancer,
conducted in a 33 county area in central and eastern North
Carolina. Cases were drawn at random from all CRC cases
reported to the North Carolina Central Cancer Registry. Controls
were selected from North Carolina Division of Motor Vehicle lists
if under the age of 65, or from a list of Medicare eligible
beneficiaries obtained from the Health Care Financing Adminis-
tration if over the age of 65, based on sampling probabilities within
blocks defined by 5-year age group, sex and race, using the
technique of randomized recruitment [45]. Vitamin D intake was
determined by daily supplement use and/or dietary intake as
determined by the Block food frequency questionnaire [46]. The
details of this study have been published previously [47].
Spanish samples were obtained through the EPICOLON
project, a prospective, multicentre, population-based epidemiology
survey studying the incidence and features of familial and sporadic
CRC in the Spanish population [48]. Cases were ascertained from
11 hospitals in Spain. All patients with a de novo histologically
confirmed diagnosis of colorectal adenocarcinoma between
November 2006 and December 2007 were selected. Patients in
whom CRC developed in the context of familial adenomatous
polyposis or inflammatory bowel disease were excluded. Demo-
graphic, clinical and tumor-related characteristics of probands, as
well as a detailed family history were obtained using a pre-
established questionnaire, and registered in a single database.
Cases and controls were matched for sex and age (65 years) and
controls were negative for personal and family cancer history.
DNA samples were extracted as previously described [49].
Clinical characteristics (Table 1) were compared between cases
and controls by race. Two-sided t-tests were used to compare
continuous variables including age and ancestry estimates. Pearson
chi-square tests of independence were used to compare categorical
variables. Because there was significant heterogeneity between the
study groups with respect to age and gender, we adjusted for these
parameters in the logistic regression models (see below).
SNP Selection
VDR tagSNPs were selected for genotyping from HapMap
(NCBI build 36) and NIEHS’ Gene SNPs database using
Haploview [50]. TagSNPs were determined using Yoruban
(YRI) data from chromosome 12 base pairs 46586959 (59 end)
to 46521297 (39 end) which includes 1.9 kb on the 59 end to
capture the promoter region. The following criteria were used to
select tagSNPs: minor allele frequency .5% (in Yoruban
population) and pair wise r
2.0.80. We identified 60 tagSNPs.
Genotyping
Germline DNA from normal tissue was prepared from both
archived formalin-fixed surgical specimens and from blood
specimens as described [46,51]. Of the 60 tagSNPs identified,
using the Sequenom MassARRAY platform, we could develop
genotyping assays on 54 SNPs. The method used for this platform
was described previously [51]. In UC and UNC AA DNA
samples, we genotyped 100 ancestry informative markers (AIMs)
from which we calculated individual estimates of global West
African ancestry [52].
Table 2. Combined analysis for VDR associations in African
Americans and Caucasians.
SNP Bp RFLP
Combined
OR Z-statistic
Combined
p-value
rs739837 46524488 0.97 20.67 0.50
rs731236 46525024 TaqI 1.01 0.17 0.87
rs7962898 46529104 ApaI 1.09 1.72 0.08
rs7967152 46530451 0.97 20.70 0.48
rs2239185 46530826 0.95 21.05 0.29
rs7971418 46531502 0.92 21.69 0.09
rs7975128 46532095 BsmI 1.07 1.41 0.16
rs7305032 46536127 0.97 20.67 0.50
rs11168267 46537809 1.06 0.62 0.53
rs11168268 46538079 0.99 20.11 0.91
rs2248098 46539623 0.92 21.66 0.10
rs987849 46540943 0.95 21.03 0.30
rs2239182 46541678 0.99 20.30 0.76
rs2107301 46541837 1.01 0.22 0.82
rs1540339 46543593 0.96 20.69 0.49
rs12717991 46545393 0.99 20.17 0.87
rs2189480 46550095 0.99 20.26 0.79
rs3819545 46551273 0.97 20.64 0.52
rs3782905 46552434 1.01 0.27 0.78
rs10735810 46559162 FokI 1.00 20.04 0.97
rs2408876 46559832 0.96 20.87 0.38
rs2254210 46559981 1.05 0.99 0.32
rs11574044 46562101 1.03 0.46 0.64
rs2238136 46563980 0.95 20.90 0.37
rs2238135 46564457 0.93 21.36 0.17
rs2853564 46564754 1.11 1.82 0.07
rs11168287 46571681 0.93 21.52 0.13
rs4328262 46571915 0.95 20.96 0.33
rs4334089 46572282 1.02 0.31 0.76
rs3890733 46575640 1.09 1.44 0.15
rs7302235 46579105 0.98 20.44 0.66
rs7136534 46580893 0.98 20.33 0.74
SNP, single nucleotide polymorphism; bp, base pair; RFLP, restriction fragment
length polymorphism; OR, combined odds ratio.
Combined analysis performed according to Zeggini et al. (ref 54).
doi:10.1371/journal.pone.0026123.t002
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(HWE) in cases and controls separately. We excluded SNPs with
HWE p-values,0.001. We used this cut-off because it is above the
significance threshold after adjustment for multiple testing.
Additional quality control measures included SNP and individual
missingness .10%. In AAs, no SNPs failed the HWE threshold
and one SNP failed the SNP missingness threshold. As result, 53
tagSNPs were included for analysis of the AA study group. In the
Caucasian study group, all 54 tagSNPs were included in the
analysis after quality controls. Genotyping rates were .98.7% for
all samples. Concordance rates for 24 duplicate samples were
99.9%.
Genetic ancestry estimation
Global individual ancestry was determined for each individual
in the UC and UNC study groups using 100 AIMs for European
and West African ancestry [51]. Individual ancestry estimates were
obtained from the genotype data using the Markov Chain Monte
Carlo (MCMC) method implemented in the program STRUC-
TURE 2.1 [53]. STRUCTURE 2.1 assumes an admixture model
using prior population information and independent allele
frequencies. The MCMC model was run using K=3 populations
(58 Europeans, 67 Native Americans and 62 West Africans) and a
burn-in length of 30,000 iterations followed by 70,000 replications.
Statistical Analysis
We tested VDR tagSNPs for association with CRC in the entire
case-control series (UC, UNC and Spain) using the pooled
analysis methodology described in Zeggini et al. [54]. For this
combined analysis, we analyzed SNPs with MAF.5% in both
the AA and Caucasian populations (n=32). We also analyzed
associations separately in the combined AA group (UC and
UNC) and in the combined Caucasian group (UC and Spain).
Associations were further analyzed in the individual study groups
from UC (separately by race), UNC and Spain. We calculated
odds ratios and 95% confidence intervals using logistic regression
assuming a log-additive genetic model. For selected SNPs, we
tested dominant and recessive genetic models as well. In the AA
study groups (UC and UNC), we controlled for individual
admixture by including global West African ancestry estimates in
the logistic regression models. In all individuals, we controlled for
age and gender in the logistic regression model. We determined
the significance of each SNP association empirically using 1000
permutations. These association tests were performed using the
program PLINK [55].
We imputed untyped SNPs using MACH v1.0 [56,57]. MACH
uses a MCMC-based algorithm to infer genotypes for individuals.
We identified an approximately 2 Mb region on chromosome 12
(45553633 to 47551615 bp) which included VDR. Since many of
Figure 1. Association of VDR tagSNPs in African Americans and Caucasians. Plot of 2log10 transformed p-values calculated for VDR tagSNPs
and adjusted for age, gender and ethnic admixture (for the African American study group only) versus nucleotide position on chromosome 12. The
arrow depicts the VDR gene, which is transcribed in direction from the telomere towards the centromere. The line shows p-value threshold
accounting for number of tests (9610
24) based on a Bonferroni correction. Results for African Americans are shown in red and Caucasians in blue.
doi:10.1371/journal.pone.0026123.g001
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haplotypes of the HapMap Data Phase III/Rel#3 (May10), we
downloaded the most recent SNP genotype data (HapMap Data
Rel#28 Phase II and III) for both the YRI and CEU populations
and phased each set in the YRI and CEU separately using
MACH and employing parameters -rounds 50 and -states 500.
We then imputed genotypes in the African-American study
groups using the phased haplotypes from the YRI population and
genotypes in the Caucasian study groups using the phased
haplotypes from the CEU population. For all two imputations,
we used the following parameters: -greedy, -rounds 100, -autoflip.
We included only markers with r
2.0.50 as a quality control and
HWE.10
25. Imputed genotypes were tested for association as
described above.
Sub-group analysis was done by gender and anatomic site
(colon versus rectum) in the AA and Caucasian groups separately.
For the UNC study group, for which we had supplement and
dietary intake data, we tested for SNP associations by vitamin D
intake. We defined vitamin D intake as a categorical variable
based on a threshold daily intake of .100 IU. To test for SNP-
vitamin D intake interaction, we performed a Breslow-Day test for
between cluster heterogeneity. We corrected for multiple hypoth-
esis testing using a Bonferroni correction. These association tests
were also performed using PLINK [55].
Results
Analysis of tagged and imputed SNPs
Under the assumption that common genetic variants in VDR
influence risk of developing CRC, we performed a combined
analysis of the entire study group, including AAs (UC and UNC)
and Caucasians (UC and Spain). This analysis did not reveal
evidence of association between VDR tagSNPs and CRC (Table 2).
In AAs, combined analysis (UC and UNC) of VDR tagSNPs did
not provide evidence for association between VDR and CRC.
(Figure 1 and Supplementary Table S1). After adjustment for age,
gender, and West African ancestry, three SNPs (rs7962898,
rs12308082, and rs11574065) had p-values#0.05, but these p-values
were not significant after adjustment for multiple testing. The SNP
with the smallestp-value was rs12308082 (OR=0.74, 95% CI [0.57–
0.96]; p=0.02). Analysis of the individual AA study groups were
consistent with the combined AA study group, in as much as each
SNP that was nominally significant in the combined study group was
nominally significantly associated with CRC in one of the two AA
study groups (Supplementary Table S2). No SNP was nominally
significant in both study groups. We noted that both rs12308082 and
the SNP with the second smallest p-value, rs11574065, (p=0.04) had
relatively low allele frequencies in controls (0.09 and 0.02,
respectively); these SNPs were monomorphic in Caucasians.
Figure 2. Association of VDR imputed SNPs in African Americans and Caucasians. Plot of 2log10 transformed p-values calculated on
imputed genotypes and adjusted for age, gender and ethnic admixture (for the African American study group only) versus nucleotide position on
chromosome 12. The line shows p-value threshold accounting for number of tests (8610
25) based on a Bonferroni correction. Results for African
Americans are shown in red and Caucasians in blue.
doi:10.1371/journal.pone.0026123.g002
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of VDR tagSNPs again did not provide evidence for association
between VDR and CRC. (Figure 1 and Supplementary Table S1).
After adjustment for age and gender, two SNPs trended toward
significance (rs107783218 and rs2853564), but as with the AA
analyses, no SNPs were significantly associated with CRC after
adjustment for multiple testing. In the UC Caucasian study group,
there was one SNP that had a p-value,0.05 (rs10783218,
p=0.02) (Supplementary Table S3), but none of the SNPs had
p-values,0.05 in the Spanish Caucasian study group. We note
that because the tagSNPs were selected based on Yoruban
genotype data, several SNPs were monomorphic or rare in
Caucasians.
Using tagSNPs, we imputed untyped markers across a 2 Mb
region on chromosome 12 including VDR. In total, we imputed
2236 SNPs in AAs and 2185 SNPs in Caucasians after applying
quality controls. After filtering out monomorphic alleles, we tested
664 imputed SNPs in AAs and 820 imputed SNPs in Caucasians.
We did not find evidence for associations between any imputed
SNPs and CRC in either study group after adjustment for multiple
testing (Figure 2).
Analysis of previously tested RFLPs
We tested SNPs that were previously studied in RFLP studies—
two directly, referred to as FokI (rs10735810) and TaqI (rs731236),
and two indirectly with tagSNPs, referred to as BsmI (tagSNP
rs7975128, r
2=1) and ApaI (tagSNP rs7962898, r
2=0.975). In the
combined analysis of the entire study group, the SNP rs7962898
tagging ApaI had the smallest combined p-value of 0.08 (Table 2).
None of the other previously reported RFLP SNPs (FokI, TaqI and
BsmI) showed evidence for association with CRC in this analysis.
We next analyzed additive, dominant and recessive models in the
AA and Caucasian study groups separately (Table 3). In AAs
(Table 3A), the FokI and TaqI SNPs were not significantly
associated with CRC; however, the SNP tagging ApaI was
nominally significant under the additive model (p=0.05). In the
analysis of AAs by individual institution (UC vs. UNC), the SNP
that tagged BsmI was nominally associated with CRC in the UC
study group (p=0.05) but not in the UNC study group (p=0.62)
(Supplementary Table S2). None of these SNPs were nominally
significant in Caucasians under any genetic model tested
(Table 3B).
Sub-group analyses
There have been previous reports of associations when stratified
by gender [18]; consequently, we further analyzed our association
results by gender in the AA and Caucasians study groups. Among
AA females, there was one SNP rs11168264 that was nominally
significant (p=0.05). This SNP is rare in Caucasians. No SNPs
were noted to be associated in the Caucasian female group
(Supplementary Figure S1 & Supplementary Table S4). In males,
there were several associations noted. Among AA males,
rs11574065 (p=0.02) and rs11574050 (p=0.009) showed evi-
dence of association. Among Caucasian males, rs2254210
(p=0.005) and rs2853564 (p=0.03) showed evidence for
association with CRC. However, none of these p-values were
significant after adjustment for multiple testing.
Because previous reports have suggested associations with
anatomic sites in the colon [37], we next considered associations
by anatomic site in the large bowel (Supplementary Figure S2 &
Supplementary Tables S5 and S6). Our sub-group analysis showed
associations primarily in the AA rectal cancer group. In the
combined AA group, four SNPs had adjusted p-values less than
0.05 (Supplementary Table S5). Of these, two SNPs rs12314197
and rs7962898 are tagSNPs for ApaI. Considering rectal cancer
Table 3. VDR RFLP associations by genetic model.
SNP RFLP Allele Model OR [95% CI] P-value
(A) African Americans
rs731236 TaqI C Additive 0.98 [0.84–1.14] 0.79
Dominant 1.03 [0.85–1.26] 0.74
Recessive 0.81 [0.56–1.15] 0.24
rs7962898 ApaI T Additive 1.15 [1.00–1.33] 0.05
Dominant 1.19 [0.97–1.46] 0.09
Recessive 1.24 [0.93–1.65] 0.14
rs7975128 BsmI T Additive 1.13 [0.97–1.31] 0.12
Dominant 1.16 [0.95–1.41] 0.15
Recessive 1.19 [0.85–1.68] 0.31
rs10735810 FokI T Additive 0.97 [0.82–1.15] 0.74
Dominant 1.01 [0.82–1.23] 0.94
Recessive 0.76 [0.47–1.24] 0.27
(B) Caucasians
rs731236 TaqI C Additive 1.04 [0.91–1.19] 0.53
Dominant 1.13 [0.93–1.36] 0.21
Recessive 0.94 [0.73–1.21] 0.64
rs7962898 ApaI C Additive 0.96 [0.85–1.10] 0.57
Dominant 0.94 [0.77–1.16] 0.58
Recessive 0.96 [0.77–1.19] 0.72
rs7975128 BsmI T Additive 1.03 [0.91–1.18] 0.63
Dominant 1.14 [0.94–1.37] 0.18
Recessive 0.89 [0.70–1.15] 0.38
rs10735810 FokI T Additive 1.00 [0.87–1.14] 0.96
Dominant 0.95 [0.79–1.14] 0.56
Recessive 1.10 [0.85–1.44] 0.47
SNP, single nucleotide polymorphism; RFLP, restriction fragment length
polymorphism; OR, odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0026123.t003
Table 4. Association of rs11574041 A allele with CRC by vitamin D intake in UNC study group.
Vitamin D intake No. cases No. controls Freq. cases Freq. controls OR P-value
$100 IU 232 214 0.05 0.15 0.30 0.0009
,100 IU 506 582 0.09 0.09 1.05 0.84
No., number; Freq., allele frequency; OR, odds ratio.
doi:10.1371/journal.pone.0026123.t004
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the ApaI tagSNPs were associated with rectal cancer in the UNC
study group; while, the other two SNPs rs3890733 and rs7302235
were associated in the UC study group. However, none of these
SNPs were significant after adjustment for multiple testing. In the
Caucasian study group, one SNP rs2853564 had evidence of
association with colon cancer (p=0.01); while not significant, this
association showed the smallest p-value after taking multiple
testing into account (p=0.28).
For the UNC study group, we tested for differences in SNP
associations by vitamin D intake. We found a significant
association for an intronic SNP rs11574041 and vitamin D intake
(Table 4). In particular, there was significant OR heterogeneity
between individuals with vitamin D intake compared to those with
no meaningful intake (OR 0.30 vs. 1.05 respectively, Breslow-Day
p=0.004). We noted a protective effect of the A allele in
individuals with high vitamin D intake (fA=0.15 vs. fU=0.05,
p=9 610
24) which was significant when accounting for the
number of SNPs tested by Bonferroni correction (p=9.3610
24).
Discussion
Study of VDR genetic variants for association with CRC in
the AA population is important given the overall higher CRC
incidence and mortality as well as lower vitamin D levels in this
population compared to other US populations. In our
association study using tagSNPs and imputed SNPs in a large
group of AAs and Caucasians, we did not find evidence of
significant associations between CRC and common genetic
variants in VDR. Our results were similar in both the combined
analysis and the analysis of ethnically-related and individual
study groups. Moreover, in our results, we found no significant
associations in our sub-group analysis by gender or anatomic
site. Overall, our results are in agreement with two recent
reports in Caucasians that also reported no evidence for
associations between VDR tagSNPs and CRC [42] or colonic
adenomas [43].
Because previous studies had sometimes found associations
between CRC and VDR RFLPs [21–28,30–37,39–41], we
performed additional genetic analyses on some of these variants;
however, FokI (rs10735810), TaqI (rs731236), and BsmI
(rs1544410) were not significantly associated with CRC in any
study group. In our study, we found a nominally significant
association in AA CRC with rs7962898, a SNP that tags the RFLP
ApaI. Previous studies have found an association with ApaI and
CRC in non-AA populations, though sample sizes were small and
both significant and non-significant results have been reported
[21,26]. Given the lack of evidence for association between CRC
and rs7962898 in Caucasians in the present study, we interpret
our nominally significant p-value with rs7962898 in AAs
cautiously. The association has not been reported previously in
this population, and it was observed in only one of the two study
groups that we analyzed (UC but not UNC).
In our UNC study group, we note a significant association
between an intronic SNP rs11574041 and vitamin D intake. To
our knowledge, this association has not been previously reported.
While this result suggests a gene-environment interaction, it should
be interpreted with caution due to the small sample size and
limited data of supplemental and dietary intake available for this
analysis. In previous case-control studies, vitamin D intake (both
dietary and supplemental) has not been an adequate proxy for
vitamin D serum levels and, therefore, probably does not reflect
vitamin D status. Our results require further study in a larger
sample preferably with data of vitamin D serum levels.
In the present study, there are several possible explanations for
the overall lack of significant associations. SNPs in the VDR gene
on their own may not increase CRC risk; however, if SNPs are
playing a role, they may interact with other SNPs or with
environmental factors to increase risk. Some differences in
associations between African American populations from different
geographic locations (UC vs. UNC) were detected, and these
differences potentially could be explained by environmental
differences between the two groups. Given that control of serum
25(OH)D3 levels have both genetic and environmental determi-
nants, we hypothesize that there are important gene-environment
interactions that together increase risk of CRC. In the present
study, we did not have access to environmental measures of
vitamin D intake for the UC and Spanish study groups, nor did we
have serum 25(OH)D3 levels for any of the study groups.
Alternatively, rare variants in VDR may increase CRC risk. In
such a genetic model, multiple rare variants with stronger effects
(e.g., ORs.1.5) could increase individual risk of CRC such that
earlier and more frequent colonoscopic screening would be
recommended. Rare variants are not well assessed using a tagSNP
approach, and, in general, larger association studies or family-
based studies are required to identify associations with rare
variants. We note that the two variants in VDR with the smallest p-
values in the present study were relatively rare.
The strengths of the current study are a large sample size
including AAs as well as a comprehensive tagSNP approach to
capture nearly all common variation in the VDR gene. Moreover,
we used imputation to obtain genotypes for untyped SNPs,
thereby increasing coverage of the VDR gene and surrounding
regions on chromosome 12. Weaknesses of this study include lack
of measures of serum vitamin D levels in all subjects; such data
would potentially uncover interactions between genotype and
environment. Moreover, we did not include SNPs that tag the
Cdx2 polymorphism in the initial tagSNP analysis, which has
yielded positive results in CRC in a previous study [17]. However,
our imputation analysis included the region harboring the Cdx2
polymorphism and did not show significant associations. Future
studies should include such environmental data such as vitamin D
intake and serum levels to determine if gene-environment
interactions influence CRC. In addition, there have been reports
of novel candidate regions associated with vitamin D levels from
genome-wide association and ChIP-sequencing studies that should
be tested for genetic association in CRC [58,59].
In summary, we found no compelling evidence for associations
between CRC and genetic polymorphisms in VDR. Although we
observed a nominally significant CRC association with a SNP that
is highly correlated with ApaI in AAs, this association was observed
in only one of the two AA study groups; moreover, associations
were not detected between CRC and other VDR tagSNPs in AAs.
In Caucasians, associations were not detected between CRC and
either previously reported VDR RFLPs or VDR tagSNPs. A
possible association between vitamin D intake and rs11574041 in
AA CRC requires further investigation.
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Figure S1 Association of VDR tagSNPs in African Amer-
icans and Caucasians by gender: (A) females and (B)
males. Plot of 2log10 transformed p-values calculated for VDR
tagSNPs and adjusted for age and ethnic admixture (for the African
American study group only) versus nucleotide position on
chromosome 12. The arrow depicts the VDR gene, which is
transcribed in direction from the telomere towards the centromere.
The line shows p-value threshold accounting for number of tests
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24) based on a Bonferroni correction. Results for African
Americans are shown in red and Caucasians in blue.
(TIF)
Figure S2 Association of VDR tagSNPs in African
Americans and Caucasians by anatomic site: (A) colon
cancer and (B) rectal cancer. Plot of 2log10 transformed p-
values calculated for VDR tagSNPs and adjusted for age, gender
and ethnic admixture (for the African American study group only)
versus nucleotide position on chromosome 12. The arrow depicts
the VDR gene, which is transcribed from right to left on the
chromosome. The line shows p-value threshold accounting for
number of tests (9610
24) based on a Bonferroni correction.
Results for African Americans are shown in red and Caucasians in
blue.
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